You just read:

Ocugen Receives FDA Orphan Drug Designation for OCU300 (brimonidine tartrate) for the Treatment of Ocular Graft Versus Host Disease

News provided by

Ocugen, Inc.

Aug 09, 2017, 07:15 ET